264 related articles for article (PubMed ID: 19053209)
1. Peptide-based vaccines for cancer: realizing their potential.
Kanodia S; Kast WM
Expert Rev Vaccines; 2008 Dec; 7(10):1533-45. PubMed ID: 19053209
[TBL] [Abstract][Full Text] [Related]
2. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
3. Development of optimized cryptic peptides for immunotherapy.
Menez-Jamet J; Kosmatopoulos K
IDrugs; 2009 Feb; 12(2):98-102. PubMed ID: 19204883
[TBL] [Abstract][Full Text] [Related]
4. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
Brockstedt DG; Dubensky TW
Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
[TBL] [Abstract][Full Text] [Related]
5. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
7. Peptides as tools and drugs for immunotherapies.
Beck A; Klinguer-Hamour C; Bussat MC; Champion T; Haeuw JF; Goetsch L; Wurch T; Sugawara M; Milon A; Van Dorsselaer A; Nguyen T; Corvaïa N
J Pept Sci; 2007 Sep; 13(9):588-602. PubMed ID: 17602441
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
Fournier P; Schirrmacher V
Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities.
Yu Z; Ren P; Zhang X; Zhang T; Ma B
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1065-71. PubMed ID: 19671026
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic peptide vaccination with leukemia-associated antigens.
Rusakiewicz S; Molldrem JJ
Curr Opin Immunol; 2006 Oct; 18(5):599-604. PubMed ID: 16870418
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based anticancer vaccines: recent advances and future perspectives.
Mocellin S; Pilati P; Nitti D
Curr Med Chem; 2009; 16(36):4779-96. PubMed ID: 19929787
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
13. Current immunotherapeutic strategies in colon cancer.
Morse M; Langer L; Starodub A; Hobeika A; Clay T; Lyerly HK
Surg Oncol Clin N Am; 2007 Oct; 16(4):873-900, x. PubMed ID: 18022550
[TBL] [Abstract][Full Text] [Related]
14. Plant production systems for vaccines.
Streatfield SJ; Howard JA
Expert Rev Vaccines; 2003 Dec; 2(6):763-75. PubMed ID: 14711360
[TBL] [Abstract][Full Text] [Related]
15. Overview of mimotopes and related strategies in tumor vaccine development.
Zhao L; Liu Z; Fan D
Expert Rev Vaccines; 2008 Dec; 7(10):1547-55. PubMed ID: 19053210
[TBL] [Abstract][Full Text] [Related]
16. Vaccine strategies for glioblastoma: progress and future directions.
Jackson C; Ruzevick J; Brem H; Lim M
Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
[TBL] [Abstract][Full Text] [Related]
17. Improving the efficacy of cancer immunotherapy.
Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy for glioma].
Izumoto S; Yoshimine T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):926-30. PubMed ID: 18652053
[No Abstract] [Full Text] [Related]
19. Peptide-Based Treatment: A Promising Cancer Therapy.
Xiao YF; Jie MM; Li BS; Hu CJ; Xie R; Tang B; Yang SM
J Immunol Res; 2015; 2015():761820. PubMed ID: 26568964
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]